Mihaela Zidarn1,2, Maša Robič1, Anja Krivec1, Mira Šilar1, Yvonne Resch-Marat3, Susanne Vrtala3, Peter Kopač1, Nissera Bajrović1, Rudolf Valenta3,4,5, Peter Korošec1. 1. University Clinic of Pulmonary and Allergic Diseases Golnik, Golnik, Slovenia. 2. Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia. 3. Division of Immunopathology, Department of Pathophysiology and Allergy Research, Centre for Pathophysiology, Infectiology, and Immunology, Medical University of Vienna, Vienna, Austria. 4. NRC Institute of Immunology FMBA of Russia, Moscow, Russia. 5. Laboratory for Immunopathology, Department of Clinical Immunology and Allergy, Sechenov First Moscow State Medical University, Moscow, Russia.
Abstract
BACKGROUND: Confirmation of the clinical relevance of sensitisation is important for the diagnosis of allergic rhinitis. OBJECTIVE: To investigate the usefulness of an in vitro basophil activation test and component-resolved diagnosis in distinguishing between symptomatic allergic rhinitis patients and asymptomatic sensitization to house dust mites (HDMs). METHODS: Thirty-six subjects with a positive skin prick test (SPT) for HDM were divided into a symptomatic (n = 17) and an asymptomatic (n = 19) group on the basis of their clinical history and a nasal provocation test. A basophil CD63 response to in vitro stimulation with Dermatophagoides pteronyssinus whole allergen extract and the IgE reactivity profiles for Der p 1, 2, 4, 5, 7, 10, 11, 14, 15, 18, 21, 23 were evaluated. Serum IgE and IgG specific to D pteronyssinus whole allergen extract and total IgE were measured. RESULTS: There were no statistically significant differences in the levels of IgE (IgE levels were higher in symptomatic patients with P = 0.055) and IgG specific to D pteronyssinus and total IgE. Symptomatic patients showed a lower threshold for in vitro basophil activation (3.33 ng/mL vs 33.3 ng/mL), a higher area under the curve (AUC) of basophil activation (171 vs 127) (P = 0.017), a higher response to positive control with anti-FcεRI stimulation (97% vs 79%) (P < 0.001), a recognition of more HDM allergens (4 vs 2) and more frequent sensitization to rDer p 7 (P = 0.016) and rDer p 23 compared to asymptomatic subjects (P = 0.018). There was a positive correlation (r = 0.63; P < 0.001) between the number of recognized allergens and the AUC of basophil activation. CONCLUSION AND CLINICAL RELEVANCE: In the subjects studied, the differences in the basophil response to D pteronyssinus allergen extract, number of recognized HDM allergens and reactivity to rDer p 7 and rDer p 23 distinguish symptomatic from asymptomatic HDM sensitisation better than SPT or allergen extract-specific IgE. Information regarding the clinical relevance of sensitization is important for the prescription of allergen-specific immunotherapy.
BACKGROUND: Confirmation of the clinical relevance of sensitisation is important for the diagnosis of allergic rhinitis. OBJECTIVE: To investigate the usefulness of an in vitro basophil activation test and component-resolved diagnosis in distinguishing between symptomatic allergic rhinitispatients and asymptomatic sensitization to house dust mites (HDMs). METHODS: Thirty-six subjects with a positive skin prick test (SPT) for HDM were divided into a symptomatic (n = 17) and an asymptomatic (n = 19) group on the basis of their clinical history and a nasal provocation test. A basophil CD63 response to in vitro stimulation with Dermatophagoides pteronyssinus whole allergen extract and the IgE reactivity profiles for Der p 1, 2, 4, 5, 7, 10, 11, 14, 15, 18, 21, 23 were evaluated. Serum IgE and IgG specific to D pteronyssinus whole allergen extract and total IgE were measured. RESULTS: There were no statistically significant differences in the levels of IgE (IgE levels were higher in symptomatic patients with P = 0.055) and IgG specific to D pteronyssinus and total IgE. Symptomatic patients showed a lower threshold for in vitro basophil activation (3.33 ng/mL vs 33.3 ng/mL), a higher area under the curve (AUC) of basophil activation (171 vs 127) (P = 0.017), a higher response to positive control with anti-FcεRI stimulation (97% vs 79%) (P < 0.001), a recognition of more HDM allergens (4 vs 2) and more frequent sensitization to rDer p 7 (P = 0.016) and rDer p 23 compared to asymptomatic subjects (P = 0.018). There was a positive correlation (r = 0.63; P < 0.001) between the number of recognized allergens and the AUC of basophil activation. CONCLUSION AND CLINICAL RELEVANCE: In the subjects studied, the differences in the basophil response to D pteronyssinus allergen extract, number of recognized HDM allergens and reactivity to rDer p 7 and rDer p 23 distinguish symptomatic from asymptomatic HDM sensitisation better than SPT or allergen extract-specific IgE. Information regarding the clinical relevance of sensitization is important for the prescription of allergen-specific immunotherapy.
Authors: D G Ebo; J Sainte-Laudy; C H Bridts; C H Mertens; M M Hagendorens; A J Schuerwegh; L S De Clerck; W J Stevens Journal: Allergy Date: 2006-09 Impact factor: 13.146
Authors: L Heinzerling; A J Frew; C Bindslev-Jensen; S Bonini; J Bousquet; M Bresciani; K-H Carlsen; P van Cauwenberge; U Darsow; W J Fokkens; T Haahtela; H van Hoecke; B Jessberger; M L Kowalski; T Kopp; C N Lahoz; K C Lodrup Carlsen; N G Papadopoulos; J Ring; P Schmid-Grendelmeier; A M Vignola; S Wöhrl; T Zuberbier Journal: Allergy Date: 2005-10 Impact factor: 13.146
Authors: J Bousquet; J M Anto; C Bachert; P J Bousquet; P Colombo; R Crameri; M Daëron; W Fokkens; B Leynaert; C Lahoz; M Maurer; G Passalacqua; R Valenta; M van Hage; R Van Ree Journal: Allergy Date: 2006-06 Impact factor: 13.146
Authors: R Valenta; M Duchene; C Ebner; P Valent; C Sillaber; P Deviller; F Ferreira; M Tejkl; H Edelmann; D Kraft Journal: J Exp Med Date: 1992-02-01 Impact factor: 14.307
Authors: Hanna Danielewicz; Artur Gurgul; Anna Dębińska; Grzegorz Myszczyszyn; Tomasz Szmatoła; Anna Myszkal; Igor Jasielczuk; Anna Drabik-Chamerska; Lidia Hirnle; Andrzej Boznański Journal: Epigenetics Date: 2020-09-09 Impact factor: 4.528
Authors: Victoria V Rodinkova; Serhii D Yuriev; Mariia V Kryvopustova; Vitalii B Mokin; Yevhenii M Kryzhanovskyi; Andrii I Kurchenko Journal: Front Immunol Date: 2022-03-22 Impact factor: 7.561